FDA Approves New Cancer Medication
Hodgkin Lymphoma Treatment May Boost Breast Cancer Risks
Rx May Offer Hope for Some Non-Hodgkin Lymphoma Patients
Non-Hodgkin Lymphoma Rx Reduced Tumors
Recent data from the Leukemia and Lymphoma Society report that there are currently over 628,000 people in the United States living with some form of lymphoma. This includes over 474,000 diagnoses of non-Hodgkin lymphoma, and over 153,000 diagnoses of Hodgkin lymphoma (HL).
Hodgkin lymphoma is distinguished from other diseases classified as lymphoma primarily because of the presence of Reed-Sternberg cells, which are large, cancerous cells found in Hodgkin lymphoma tissues. Non-Hodgkin lymphomas (NHL) represent a varied group of diseases...